Select Medical Hldgs Raises FY2024 Adj EPS Guidance from $1.96-2.20 to $2.09-2.20 vs $1.86 Est; Raises FY2024 Sales Guidance from $6.90B-7.10B to $6.95B-7.15B vs $7.03B Est
Portfolio Pulse from Benzinga Newsdesk
Select Medical Holdings has raised its FY2024 adjusted EPS guidance to $2.09-2.20, surpassing the analyst estimate of $1.86. The company also increased its FY2024 sales guidance to $6.95B-7.15B, compared to the $7.03B estimate.
October 31, 2024 | 8:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Select Medical Holdings has increased its FY2024 adjusted EPS and sales guidance, both exceeding analyst estimates. This positive revision suggests strong financial performance expectations.
The upward revision of both EPS and sales guidance indicates a strong financial outlook for Select Medical Holdings. The new guidance surpasses analyst estimates, which is likely to positively influence investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100